Latest filing published 24 Jan 2023 for Pear Therapeutics, Inc., €7,401.
No signal scores available.
Katherine Jeffery discloses dealings in Pear Therapeutics, Inc. to SEC (Form 4). The record holds 2 filings, for trades running from 14 January 2023 to 20 January 2023.
Every open-market trade on record is a sale: 1 sale worth €7,401. Besides market trades, the filings include 1 option exercise.
The newest entry dates from 24 January 2023: an open-market sale of €7,401, in Pear Therapeutics, Inc. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations